Screening for Prostate Cancer in Military Populations
Author: Moul, Judd W.
Source: Military Medicine, Volume 170, Number 11, November 2005 , pp. 905-914(10)
Abstract:With the widespread use of the prostate-specific antigen (PSA) test, smaller cancers are being detected among younger men and 5-year, cancer-specific, survival rates are on the rise. Although this lead-time effect may not translate into long-term improvement, these changes are a necessary prerequisite to effective screening. For high-risk patients, i.e., men with a family history of the disease and African American men, a strategy consisting of annual PSA blood testing and digital rectal examination for men ≥40 years of age appears prudent. Many low/average-risk men of age 40 to 49 also request testing, and it is reasonable to offer testing and risk assessment to them. The exact screening threshold for total PSA levels for these men is not known, but 95% have PSA levels of ≤1.5 to 2.5 ng/mL. PSA velocity (<20% per year), percentage of free PSA (>18–25%), and complexed PSA levels may be used to help determine risk. More study of young men is needed.
Document Type: Research article
Publication date: 2005-11-01
- Military Medicine is the Association's official monthly journal. The objective of the Journal is to promote awareness of Federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to Federal healthcare. Its mission is: To increase healthcare education by providing scientific and other information to its readers; to facilitate communication; and to offer a prestige publication for members' writings.
Military Medicine's 5-year Impact Factor: 1.061
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Reviewer Information
- ingentaconnect is not responsible for the content or availability of external websites